AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks - Reuters

Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks - Reuters

Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks Reuters

March 12, 2026 at 09:01 AM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

USA

Tags

drug safety health risks impurity lilly medicine weight loss weight-loss drug

All Coverage

Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxOV0dqMWtESjYyck5UMktyX3E1S3Q4cWVHR2UtZWVKYmpHLW0xREpuWThOOUFtcVcwMGx6ZG9nOG14MXBBQmVTOFl4T0V4XzkzU3ZMSlhJd2VpeWNFU1pGWXJGZTkxelRMcGl5Wko0cjc5TkhrUm5PUnBVNVdwUTRRc0FyY1dqVDZHQXhFZWV1U243UjlUSXBsajVFeVh5XzJpM1lXMGlwNld1RkdaWk9RUHRyQ0hmOWE3dU5yZlVZUDN0Y0VWSU1hREJwYUVpMVdHSHJqWGV0YTRrNkJPbWptNXdscnZLdw?oc=5" target="_blank">Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%

Similar Stories

Related coverage based on topic and tags

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com

August 12, 2026 at 10:27 AM

Novo CEO says obesity market won't be winner-take-all battle with Lilly - reuters.com

Novo CEO says obesity market won't be winner-take-all battle with Lilly reuters.com

August 13, 2026 at 10:02 AM

Prader-Willi experts flag safety risks linked to Neurocrine's rare disease drug - Reuters

Prader-Willi experts flag safety risks linked to Neurocrine's rare disease drug Reuters

August 12, 2026 at 04:25 PM

Novo begins study to find lowest effective dose for Wegovy pill - Reuters

Novo begins study to find lowest effective dose for Wegovy pill Reuters

August 19, 2026 at 03:26 PM

New weight-loss pill approved for use in UK

Foundayo is made by Eli Lilly, the drug firm behind the Mounjaro jab.

August 10, 2026 at 03:25 PM

Lawsuit against Bristol Myers over delayed cancer drug is revived - Reuters

Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters

August 13, 2026 at 06:00 PM